Vasu, N., Perumal, T., Suvaithenamudhan, S., Seetharaman, P. K., Ramalingam, K. R., & Sivapunniyam, A. (2026).
“Green synthesis of ZnO-CuO Nanocomposites for Dengue Vector Control and Antibacterial Applications”,
Acta Tropica, 107981.
```
Venkatesan, S., Rajagopal, A., Ramajeevan, G., Suvaithenamudhan, S., Balasubramanyam, M., Mohan, V., & Manickam, N. (2025).
“Aegle marmelos attenuates high glucose induced renal cell fibrosis via redox homeostasis maintenance and gasotransmitters modulation”,
Phytomedicine Plus, 100942.
Vedhamani J, Paul Ajithkumar I, Mathivanan JS, Raja Namasivayam S, Vasavi C and Suvaithenamudhan S (2025).
“Pharmacokinetics and computational profiling of Spinifex littoreus derived bioactive compounds against the Omicron XBB.1 variant”,
World Academy of Sciences Journal, 7(6), 102.
Pathoor, N. N., Ganesh, P. S., Anshad, A. R., Gopal, R. K., Ponmalar, E. M., Suvaithenamudhan, S., Rudrapathy, P., & Shankar, E. M. (2025).
“3-Hydroxybenzoic acid inhibits the virulence attributes and disrupts biofilm production in clinical isolates of Acinetobacter baumannii”,
European Journal of Clinical Microbiology & Infectious Diseases, 44(3), 653–669.
Sharon John, A., Alagendran, S., Sivaprakasam, B., Mohan Ramaswamy, M., Selvaraj, K., Ramanathan, S., Suvaithenamudhan, S. (2025).
“Impact of artificial intelligence and digital twin technology on cardiovascular disease diagnosis and management challenges and future directions (Review)”,
World Academy of Sciences Journal, 7(4), 1-12.
Selvavinayagam ST, Sankar S, Yong YK, Suvaithenamudhan S et al. (2024).
“Emergence of SARS-CoV-2 Omicron Variant JN.1 in Tamil Nadu, India - Clinical Characteristics and Novel Mutations”,
Scientific Reports. Contributed equally to this study.
Selvavinayagam ST, Suvaithenamudhan S, et al. (2024).
“Genomic surveillance of omicron B.1.1.529 SARS-CoV-2 and its variants between December 2021 and March 2023 in Tamil Nadu, India-A state-wide prospective longitudinal study”,
Journal of Medical Virology, 96(2), e29456.
Jay Shree Mathivanan, Victor Violet Dhayabaran, Mary Rajathei David, Muthugobal Bagayalakshmi Karuna Nidhi, Karuppasamy Muthuvel Prasath, Suvaithenamudhan S. (2024).
“Application of Deep Learning Neural Networks in Computer Aided Drug Discovery: A Review”,
Current Bioinformatics, 19(9), 851-858.
Sivaprakasam T. Selvavinayagam, Sree J. Karishma, Kannan Hemashree, Yean K. Yong, Suvaithenamudhan S, et al. (2023).
“Clinical characteristics and novel mutations of omicron subvariant XBB in Tamil Nadu, India–a cohort study”,
The Lancet Regional Health - Southeast Asia, 9, 100272.
Suvaithenamudhan S and Parthasarathy S (2023).
“In silico Studies on Potential Inhibitors of the Penicillin Binding Protein 2B (PBP2B) of the Resistant G54 and Intermediate-resistant Hungary 19A-6 and SP195 Strains of Streptococcus Pneumoniae”,
Letters in Drug Design & Discovery, 20(7), 863-880.
Vasthi Gnana Rani, Perumal Thangamathi, Balasubramanian Harihar, Sivapunniyam Ananth, Suvaithenamudhan S (2023).
“Evaluation and assessment of nutritional composition for quality profiling of Phoenix dactylifera cultivars using multivariate analytical tools”,
Ecological Genetics and Genomics, 27, 100173.
Selvavinayagam ST, Yong YK, Joseph N, Hemashree K, Tan HY, Zhang Y, Rajeshkumar M, Kumaresan A, Kalpana R, Kalaivani V, Monika AVD, Suvaithenamudhan S, et al. (2022).
“Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants”,
Frontiers in Public Health, 10, 1018399.
Suvaithenamudhan S, Ananth, S., Vanitha, M., Dhayabaran, VV., Parthasarathy, S., Sankar Ganesh, P., Shankar, EM (2022).
“In Silico Evaluation of Bioactive Compounds of Artemisia pallens Targeting the Efflux Protein of Multidrug-Resistant Acinetobacter baumannii (LAC-4 Strain)”,
Molecules, 27(16), 5188.
Muthugobal, BKN., Ramesh, G., Parthasarathy S., Suvaithenamudhan S, et al. (2022).
“GenNBPSeq: Online Web Server to Generate Never Born Protein Sequences Using Toeplitz Matrix Approach with Structure Analysis”,
Current Bioinformatics, 17(7), 565–577.
Ganeshkumar, A., Suvaithenamudhan S., & Rajaram, R. (2021).
“In Vitro and In Silico Analysis of Ascorbic Acid Towards Lanosterol 14-α-Demethylase Enzyme of Fluconazole-Resistant Candida albicans”,
Current Microbiology, 78(1), 292–302.
Muthugobal, B., Ramesh, G., Parthasarathy, S., Suvaithenamudhan S., & Muthuvel Prasath, K. (2020).
“Gray code representation of the universal genetic code: Generation of never born protein sequences using Toeplitz matrix approach”,
BioSystems, 198, 104280.
Ganeshkumar, A., Suvaithenamudhan S, et al. (2020).
“New insight of red seaweed derived Callophycin A as an alternative strategy to treat drug resistance vaginal candidiasis”,
Bioorganic Chemistry, 104, 104256.
Margret AA, Dhayabaran VV, Suvaithenamudhan S, Parthasarathy S (2019).
“Analysing the antidepressant and drug efflux competence of Clitoria ternatea L. as P-glycoprotein inhibitor to facilitate blood brain barrier”,
Acta Scientiarum Biological Sciences, 41, e46629-e46629.
Muthukumar S, Rajesh D, Selvam RM, Saibaba G, Suvaithenamudhan S, et al. (2018).
“Buffalo nasal odorant-binding protein (bunOBP) and its structural evaluation with putative pheromones”,
Scientific Reports, 8(1), 9323.
Karthikeyan BS, Suvaithenamudhan S, et al. (2018).
“Analysis of Species-Selectivity of Human, Mouse and Rat Cytochrome P450 1A and 2B Subfamily Enzymes using Molecular Modeling, Docking and Dynamics Simulations”,
Cell Biochemistry and Biophysics, 76(1-2), 91-110.
Suvaithenamudhan S and Parthasarathy S (2017).
“Molecular dynamics simulation of novel potential inhibitors for penicillin binding protein 2B of the resistant 5204 strain of Streptococcus pneumoniae”,
Current Computer Aided Drug Design, 13(3), 234-248.
Saravanan KM, Suvaithenamudhan S, Parthasarathy S, Selvaraj S (2017).
“Pairwise contact energy statistical potentials can help to find probability of point mutations”,
Proteins: Structure, Function & Bioinformatics, 85(1), 54-64.
Suvaithenamudhan S and Parthasarathy S (2016).
“Structure Based Virtual Screening for the Identification of Potential Inhibitors for Penicillin Binding Protein 2B of the Resistant 5204 Strain of Streptococcus pneumoniae”,
Current Bioinformatics, 11(1), 66-78.
Margret AA, Begum TN, Parthasarathy S, Suvaithenamudhan S (2015).
“A Strategy to Employ Clitoria ternatea as a Prospective Brain Drug Confronting Monoamine Oxidase (MAO) Against Neurodegenerative Diseases and Depression”,
Natural Product Research, 5(6), 293-306.
Suvaithenamudhan S and K. Thiyagesan (2011).
“Phytochemical screening to find a potential inhibitor of plasmepsin, a key enzyme in the life cycle of Plasmodium”,
J. Sci. Trans. Environ. Technov., 5(1), 15-18.
```
2. Memberships
Life Member of Indian Association for the Cultivation of Science.